Trial Profile
A Randomised Controlled Clinical Trial of the Efficacy of HAART Intensification With Maraviroc in HIV Virally Suppressed Patients With Cognitive Impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Pharmacodynamics
- Acronyms HANDmac
- 13 Apr 2016 Status changed from not yet recruiting to completed.
- 10 Oct 2011 New trial record